Trials / Unknown
UnknownNCT05389280
Impact of Acute Kidney Injury on Sarcopenia and Frailty in Patients With Liver Cirrhosis
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 80 (estimated)
- Sponsor
- Kangbuk Samsung Hospital · Academic / Other
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this prospective observational study is to evaluate the impact of acute kidney injury on sarcopenia and frailty in patients with liver cirrhosis.
Detailed description
The aim of this prospective study is to collect data on patients with liver cirrhosis and to investigate the impact of acute kidney injury on sarcopenia and frailty in patients with liver cirrhosis. If patients agree to participate in this clinical trial, the patients' data (such as age, sex, height, weight, nutrition status \[RFH-NPT\], history of medication, laboratory findings, endoscopic findings, and radiologic findings) will be collected in a research database. Renal injury was measured using conventional and novel serum biomarkers (serum creatinine, cystatin-C, neutrophil gelatinase-associated lipocalin, kidney injury molecule 1, and interleukin-18. Sarcopenia was evaluated using skeletal muscle index on abdominal computed tomography. Frailty was measured using Liver Frailty Index. The research database will be updated to include data on patients' disease outcomes and follow-up care.
Conditions
Timeline
- Start date
- 2022-03-23
- Primary completion
- 2022-12-31
- Completion
- 2023-03-31
- First posted
- 2022-05-25
- Last updated
- 2022-05-25
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT05389280. Inclusion in this directory is not an endorsement.